Purple Biotech PPBT
NASDAQ PPBT
$1.15 +0.06 (+5.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Non Operating Income (2021 - 2025)

Updated

Purple Biotech's Non Operating Income came in at -$147,000 for Q2 2025, compared with -$1.04 million a year earlier.

Analysis

Purple Biotech (PPBT) Non Operating Income (2021 - 2025) Analysis & Trends

Over the trailing twelve months to Jun 30, 2025, Purple Biotech reported Non Operating Income of -$3.29 million; for FY2023, it came in at -$2.29 million.

  • Going back by year, Non Operating Income was -$843,000 in FY2022, -$108,000 in FY2021, $15.46 million in FY2020 and -$1.48 million in FY2019.
  • The Q2 2025 figure represents the highest quarterly Non Operating Income since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 387.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Purple Biotech 537,659.78 -32.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -147,000.00
Jun 30, 2024 -1.04 Mn
Sep 30, 2023 -692,000.00
Jun 30, 2023 25,000.00
Dec 31, 2022 -558,000.00
Sep 30, 2022 -232,000.00
Jun 30, 2022 -38,000.00
Dec 31, 2021 13,000.00
Sep 30, 2021 -47,000.00
Jun 30, 2021 24,000.00
Mar 31, 2021 -98,000.00
API Access

Purple Biotech Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=PPBT&period=max&api_key=YOUR_API_KEY